SCHEMBL23869113

SCHEMBL23869113

c1ccc(-c2nc(-c3ccc(-c4ccc5ccccc5c4)cc3)nc(-c3ccc4c(c3)[Si](c3ccccc3)(c3ccccc3)c3ccc5ccccc5c3-4)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.36
ALDH1A1 P00352 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
KDM4E B2RXH2 2/20 0.36
TP53 P04637 2/20 0.36
HSD17B10 Q99714 2/20 0.36
CYP1A2 P05177 1/20 0.36
GPR84 Q9NQS5 2/20 0.34
AURKA O14965 1/20 0.34
AURKB Q96GD4 1/20 0.34
ESR1 P03372 4/20 0.33
ESR2 Q92731 4/20 0.33
CYP17A1 P05093 1/20 0.33
CYP19A1 P11511 1/20 0.33
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33
ALOX5 P09917 1/20 0.32
MAPT P10636 3/20 0.32
NPC1 O15118 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23869243 1.00 SMN1; SMN2 (0.36) SMN1; SMN2ALDH1A1MEN1KMT2AKDM4E
SCHEMBL23869128 0.98 SMN1; SMN2 (0.34) SMN1; SMN2ALDH1A1MEN1KMT2AKDM4E
SCHEMBL23869244 0.89 MAPT (0.38) SMN1; SMN2ALDH1A1KDM4ETP53HSD17B10
SCHEMBL23868950 0.87 MEN1 (0.40) SMN1; SMN2ALDH1A1MEN1KMT2AKDM4E
SCHEMBL23868753 0.87 MEN1 (0.40) SMN1; SMN2ALDH1A1MEN1KMT2AKDM4E
SCHEMBL23869117 0.87 ALDH1A1 (0.34) SMN1; SMN2ALDH1A1MEN1KMT2AKDM4E
SCHEMBL23869111 0.86 ALDH1A1 (0.36) SMN1; SMN2ALDH1A1MEN1KMT2AKDM4E
SCHEMBL23869127 0.86 ALDH1A1 (0.36) SMN1; SMN2ALDH1A1MEN1KMT2AKDM4E
SCHEMBL23868936 0.85 SMN1; SMN2 (0.36) SMN1; SMN2ALDH1A1MEN1KMT2AKDM4E
SCHEMBL23869097 0.85 SMN1; SMN2 (0.36) SMN1; SMN2ALDH1A1MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210300951-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2021-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210300951-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE OR10J3, OCIAD2, OCIAD1 SMN1; SMN2 3974/4885ALDH1A1 201/4885MEN1 2890/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.